உச்சம் ஆய்வகங்கள் பிரைவேட் லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share
Bhubaneswar: Apex Laboratories Private Limited, a Chennai based pharmaceutical company known for its cutting-edge research and innovation, introduces Clevira, an antiviral herbal formulation.
Clevira was developed primarily to treat dengue patients in 2017. Last year as the COVID-19 cases surged in the country, it was repurposed as supportive treatment for mild to moderate COVID symptoms. The product is available across India and is priced at Rs 11 per tablet.
A clinical trial was conducted on 100 people in May-June 2020 and the results were promising.
During the 30 days trial, conducted at Government Medical College, Omandurar Government Estate Chennai, after approval from the Tamil Nadu government, the selected 100 participants were randomized into 2 Groups with 50 patients in each: the control group comprised of patients diagnosed with SARS-CoV-2 infection received standard care treatment as per hospital regulation as well as the WHO/ICMR guidelines. The t ....

Tamil Nadu , Karthik Shanmugam , C Arthur Paul , Pvt Ltd , Apex Laboratories Pvt Ltd , Indian Council Of Medical Research , Government Medical College , International Business , Apex Laboratories Private , Disciplinary Technical Review Committee , Ayurvedic Sciences , Government Of India Ministry , Central Council For Research , Apex Laboratories Private Limited , Omandurar Government Estate Chennai , Executive Director , Manager International Business , Apex Laboratories , Erythrocyte Sedimentation Rate , Indian Council , Medical Research , Central Council , Interdisciplinary Technical Review Committee , தமிழ் நாடு , பிரைவேட் லிமிடெட் , உச்சம் ஆய்வகங்கள் பிரைவேட் லிமிடெட் ,